Navigation Links
Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
Date:8/11/2008

- Peregrine Achieves Milestone as Third Phase II Trial in Its Bavituximab

Cancer Program Begins Patient Enrollment and Dosing -

TUSTIN, Calif., Aug. 11 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) today announced that patient screening and dosing has begun in a Phase II trial designed to evaluate the safety and efficacy of bavituximab in combination with chemotherapy in patients with advanced breast cancer. The new trial is the second Phase II study evaluating bavituximab in advanced breast cancer patients, and Peregrine also is conducting a third Phase II combination therapy trial of bavituximab in non-small cell lung cancer (NSCLC) patients. The primary objective of the new breast cancer study is to assess the overall tumor response rate to the combination of bavituximab with carboplatin and paclitaxel.

"The combination of bavituximab with the chemotherapy drugs carboplatin and paclitaxel performed well in an earlier Phase I study, and we look forward to learning more about bavituximab's potential in this larger breast cancer study," said Steven W. King, president and CEO of Peregrine. "With three Phase II studies now underway, we look forward to significant clinical data being generated throughout the rest of this year."

In the trial's two-stage design, up to 15 patients with advanced breast cancer will be enrolled initially. The study will then be expanded up to a total of 46 patients if promising results are observed. Secondary objectives of the trial include measuring time to tumor progression, duration of response, overall patient survival and safety parameters. Tumor response will be evaluated using Response Evaluation Criteria in Solid Tumors (RECIST) parameters. Patients
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
2. Peregrine Reports Data Showing Bavituximabs Potential to Shrink Prostate Tumors
3. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
4. Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer
5. Peregrine Pharmaceuticals Doses First Patient in Clinical Trial of Bavituximab in HCV Patients Co-Infected With HIV
6. Peregrine Pharmaceuticals Submits Clinical Protocol for New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer
7. New Data Confirms That a Selective, Fully Human Anti-VEGF Antibody Being Developed by Peregrine is as Effective as Avastin(R) in Preclinical Cancer Models
8. Peregrine Announces Addition of The Johns Hopkins Hospital as Study Site for Bavituximab Trial in HCV Patients Co-Infected With HIV
9. Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer
10. Peregrine Pharmaceuticals Receives Approval to Conduct a Second Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
11. Peregrine Pharmaceuticals Opens Enrollment in Phase II Clinical Trial of Bavituximab in Patients with Advanced Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... -- According to a new market research report ... Cord Stimulation, Transcranial Magnetic Stimulation), Application (Depression, Parkinson,s, Tinnitus, Alzheimer,s, ... by MarketsandMarkets, the global Neuromodulation Market is estimated at $3.65 ... by 2020, at a CAGR of 11.2% during the forecast ... market data T ables and ...
(Date:7/2/2015)... 2, 2015  The Green Exchange, Inc., the developer,s ... HIPAA compliant mobile app that connects cannabis growers directly ... marijuana, announced today that their service provides the fastest ... and more than half a dozen other delivery apps ... Cannabis is unique in that it connects growers ...
(Date:7/2/2015)... DURHAM, N.C. , July 2, 2015 ... its acquisition of assets related to the ion channel ... that had previously been obtained as part of Pfizer,s ... all of Pfizer,s rights to the "Icagen" name and ... will provide comprehensive services for ion channel and transporter ...
Breaking Medicine Technology:Neuromodulation Market Worth $6.20 Billion by 2020 2Neuromodulation Market Worth $6.20 Billion by 2020 3Neuromodulation Market Worth $6.20 Billion by 2020 4New Cannabis Delivery App Gets Product to Patient in Under 7 Minutes 2Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 2Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 3Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 4
... -- Vinod Gupta grew up in a family of self-made ... still works as a physician. So it,s no surprise a ... American Dream by forming his own company, Business Research Services. ... launched its initial public offering in 1993. It eventually became ...
... Dicom Systems ( http://www.dcmsys.com ), healthcare IT company ... selection as the Vendor Neutral Archive (VNA) vendor of ... group. Dicom Systems, VNA works with ... turn your current storage to your PACS archive at ...
Cached Medicine Technology:B2B Omaha Magazine Features Vin Gupta in Latest Edition Guru Credits Education as the Reason For His Success 2B2B Omaha Magazine Features Vin Gupta in Latest Edition Guru Credits Education as the Reason For His Success 3ONRAD, Inc. Chooses Dicom Systems' Vendor Neutral Archive 2
(Date:7/3/2015)... , ... July 03, 2015 , ... " Selfie on ... which features the latest and coolest technology products available to consumers. Amanda Forstrom, a ... how these selfie sticks are great for documenting memories. , Almost every smartphone has ...
(Date:7/3/2015)... ... ... The Celebrity Dresses is currently running a promotion through July 30th. Anyone who ... opportunity to get 10% discount on orders that are over $100. , The promotion ... coupon codes or remember redemption codes. , There is a low price guarantee ...
(Date:7/2/2015)... ... July 02, 2015 , ... sweetFrog Enterprises, LLC. is ... is now the 19th sweetFrog store located in the Lone Star State. The premium ... growing companies in 2014. , The store, which opened July 1 at Duke’s Travel ...
(Date:7/2/2015)... ... July 02, 2015 , ... When Walker ... at the University of Minnesota, they knew it would save the university energy ... an award-winning choice: the total energy savings after installation was an impressive 89 ...
(Date:7/2/2015)... ... ... Patrick Achebe realized that the gift of poetry was fully in him, as beautiful phrases ... and three years later he was publishing an entire book of poetry. He knew there ... have always believed that the best way to lift yourself up, is in the effort ...
Breaking Medicine News(10 mins):Health News:Learn How to Take Selfies like Kendall Jenner 2Health News:Celebrity Fashion Summer Party Dresses on sale at TheCelebrityDresses.com 2Health News:sweetFrog Expands Texas Footprint with Location in Canton 2Health News:Kenall’s TekDek™ Helps University Achieve Award-Winning Energy Savings in Parking Structure Lighting Retrofit 2Health News:Patrick Achebe Releases Debut Book, Whispering Waves: Poems for Everyday Grace 2
... “mind is going” may be losing a part of their ... in the September 12, 2006, issue of Neurology, the scientific ... ,The study, which looked at 120 people over the age ... but still had normal performance on memory tests had reduced ...
... the first case of bird flu has been reported in a ... ,The fatal virus was confirmed on Sept.6 and was affecting ... Bird Flu Sam Okware. ,He said, "I have directed ... South Sudan region to strengthen their task forces on bird flu ...
... could be developed from the findings of a psychiatrist ... estimated 3 million Americans. Dr. Gerald Maguire of the ... Indevus Pharmaceuticals in the effort to find a cure. ... gave hopeful results, according to the company. However, even ...
... study published in PLoS Medicine online says that the life ... say an Asian-American woman may live// two decades longer than ... ,"The evidence is really quite clear that most of the ... in young and middle-aged adult men and women and most ...
... to severe memory loss improved their memories while ... ,Researchers, who examined 134 men and ... across the United States, found attention and verbal ... patients who took rivastigmine for 12 weeks compared ...
... seven months after banning the import of poultry products ... officials are making// arrangements to allow "restricted" processed chicken ... India's West Bengal state has been identified from where ... frozen or chilled chicken would be dressed, the innards ...
Cached Medicine News:Health News:Forgetful? You May Be Losing More Than Just Your Memory 2Health News:Drug Improves Memory Loss for Traumatic Brain Injury Patients 2Health News:India to Revive Exporting of Processed Chicken to Bhutan 2
The full body blanket provides coverage to the entire patient....
The torso blanket is utilized during surgical procedures that require access to the lower half of the body. Blanket design allows for right or left side IV access. A clear drape is included to cover ...
The torso blanket is designed to affix to the lower abdominal area and cover the upper half of the body....
The fabric is antistatic and non-linting and is both oil and water repellent.These superior blankets are an environmental friendly alternative to disposable blankets....
Medicine Products: